0001651308-20-000074.txt : 20200619
0001651308-20-000074.hdr.sgml : 20200619
20200619160934
ACCESSION NUMBER: 0001651308-20-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200617
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wu Xiaobin
CENTRAL INDEX KEY: 0001739452
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37686
FILM NUMBER: 20975722
MAIL ADDRESS:
STREET 1: C/O MOURANT OZANNES CRP SVCS CAYMAN LTD
STREET 2: 94 SOLARIS AVENUE
CITY: CAMANA BAY, GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BeiGene, Ltd.
CENTRAL INDEX KEY: 0001651308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981209416
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
BUSINESS PHONE: 13459494123
MAIL ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
4
1
wf-form4_159259735674939.xml
FORM 4
X0306
4
2020-06-17
0
0001651308
BeiGene, Ltd.
BGNE
0001739452
Wu Xiaobin
C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
94 SOLARIS AVENUE
CAMANA BAY, GRAND CAYMAN
E9
KY1-1108
CAYMAN ISLANDS
0
1
0
0
President & GM China
Ordinary Shares
2020-06-17
4
A
0
134147
0
A
1514562
D
American Depositary Shares
15365
D
American Depositary Shares
4000
I
By Wife
Share Option (Right to Buy)
13.42
2020-06-17
4
A
0
756821
0
A
2030-06-16
Ordinary Shares
756821.0
756821
D
Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.
Each American Depositary Share represents 13 Ordinary Shares.
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.
/s/ Scott A. Samuels, as Attorney-in-Fact
2020-06-19